Etiological Pattern of Liver Cirrhosis: Experience at a Hospital in Southwestern Colombia

Authors

DOI:

https://doi.org/10.22516/25007440.1507

Keywords:

Liver cirrhosis, causality, immunity, mordibity, prevalence

Abstract

Introduction: Liver cirrhosis is a leading cause of morbidity and mortality worldwide and in Colombia. Its most common etiologies have traditionally been chronic alcohol consumption and viral infections due to hepatitis B and C. However, recent decades have shown a shift in the etiological profile, with an increase in metabolic dysfunction–associated liver disease and autoimmune conditions.

Objective: To determine the etiology of liver cirrhosis in patients treated at a tertiary care hospital (Nariño, Colombia) during the period 2022–2023.

Methods: A cross-sectional descriptive observational study was conducted. Medical records of patients treated at Fundación Hospital San Pedro with a diagnosis of liver cirrhosis were reviewed. Statistical analysis was performed using Microsoft Excel 365, and approval was obtained from the hospital ethics committee.

Results: A total of 120 patients were analyzed, with a mean age of 66.4 years; females predominated (52.5%), and most patients were from the department of Nariño (90.83%). Clinically, 49.2% presented with ascites, 42.5% with upper gastrointestinal bleeding, and 17.5% with hepatic encephalopathy. According to the Child–Pugh classification, 39.2% were stage B and 25.8% stage C. The most frequent etiology was cryptogenic (35.8%), followed by autoimmune (25.0%) and alcohol-related (15.0%). In-hospital mortality was 11.7%.

Conclusions: Liver cirrhosis showed a predominantly cryptogenic etiological profile, with a high burden of advanced disease at diagnosis. The high frequency of autoimmune and steatosis-associated etiologies suggests a shift from the traditional etiological pattern observed in previous decades.

Downloads

Download data is not yet available.

Author Biographies

Nasly Violedy Ipia Ordoñez, Universidad Cooperativa de Colombia

Resident Physician, Specialist in Internal Medicine, Universidad Cooperativa de Colombia. Pasto, Colombia.

Julie Andrea Benavides Melo, Universidad Cooperativa de Colombia

Biologist, Master’s Degree in Clinical Epidemiology, School of Medicine, Universidad Cooperativa de Colombia, GIISE Research Group. Pasto, Colombia.

Melissa Bastidas Riascos, Fundación Hospital San Pedro

Gastroenterologist, Specialist in Internal Medicine, Fundación Hospital San Pedro. Pasto, Colombia.

Simón Darío Madroñero Muñoz, Universidad Cooperativa de Colombia

Resident Physician, Specialist in Internal Medicine, Universidad Cooperativa de Colombia. Pasto, Colombia.

Anyela Jemima Vélez Rosales, Universidad Cooperativa de Colombia

Medical Student, Universidad Cooperativa de Colombia. Pasto, Colombia.

Diego Fernando Taramuel Gómez , Universidad Cooperativa de Colombia

Specialist in Internal Medicine, Graduate Faculty Member, Universidad Cooperativa de Colombia. Pasto, Colombia.

References

Wong RJ, Singal AK. Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014-2019. JAMA Netw Open. 2020;3(2):e1920294. https://doi.org/10.1001/jamanetworkopen.2019.20294

Smith A, Baumgartner K, Bositis C. Cirrhosis: Diagnosis and management. Am Fam Physician. 2019;100(12):759-70. PMID: 31845776

Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-71. Epub 2018 Sep 26. https://doi.org/10.1016/j.jhep.2018.09.014

Bejarano-Ramírez DF, Alvis-Zakzuk NJ, Carrasquilla G, Porras-Ramírez A, Vera-Torres A. Economic burden of liver disease in Colombia. Rev Colomb Gastroenterol. 2023;38(2):155-66. https://doi.org/10.22516/25007440.1007

Luján-Ramos MA, Díaz-Ramírez GS, Martínez-Casas OY, Morales-Ortíz AF, Donado-Gómez JH, Restrepo-Gutiérrez JC, et al. Caracterización de pacientes con cirrosis hepática y bacteriemia de un hospital universitario en Medellín, Colombia. Rev Colomb Gastroenterol. 2020;35(4):421-30. https://doi.org/10.22516/25007440.557

Prieto O, J. E., Sánchez P, S., Prieto, R. G., Rojas D, E. L., González, L., & Mendivelso, F. (2016). Características clínicas y descompensación en pacientes con cirrosis hepática atendidos en dos centros de hepatología en la ciudad de Bogotá D.C., 2010-2014. Revista Colombiana De Gastroenterología, 31(1), 1-8. https://doi.org/10.22516/25007440.66

Artola M, Rubino F. Etiología de la cirrosis: cambios epidemiológicos entre los periodos 1995-2002 y 2010-2017. Rev Gastroenterol Perú. 2020;50(3):245-53. https://doi.org/10.52787/JEFK3470

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359-76. https://doi.org/10.1016/S0140-6736(21)01374-X

Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014-48. https://doi.org/10.1002/hep.31884

Villanueva C, Albillos A, Genescà J, Garcia-Pagán JC, Calleja JL, Aracil C, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomized, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393(10181):1597-608. https://doi.org/10.1016/S0140-6736(18)31875-0

Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol. 2015;21(41):11567-83. https://doi.org/10.3748/wjg.v21.i41.11567

Castera L, Yuen Chan HL, Arrese M, Afdhal N, Bedossa P, Friedrich-Rust M, et al. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-64. https://doi.org/10.1016/j.jhep.2015.04.006

Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med. 2016;375(8):767-77. https://doi.org/10.1056/NEJMra1504367

Gonzalez-Chagolla A, Olivas-Martinez A, Ruiz-Manriquez J, Servín-Rojas M, Kauffman-Ortega E, Chávez-García LC, et al. Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico. Lancet Reg Health Am. 2022;10:100235. https://doi.org/10.1016/j.lana.2021.100151

Vélez-Aguirre JD, Lepesqueur-Guillén L, Yepes-Barreto I. Nonalcoholic steatohepatitis: An emerging cause of cirrhosis in Colombia. Rev Colomb Gastroenterol. 2022;37(2):136-44. https://doi.org/10.22516/25007440.783

Flemming JA, Djerboua M, Groome PA, Booth CM, Terrault NA. NAFLD and alcohol-associated liver disease will be responsible for almost all new diagnoses of cirrhosis in Canada by 2040. Hepatology. 2021;74(6):3330-44. Epub 2021 Aug 15. https://doi.org/10.1002/hep.32032

Figure 1. Percentage Distribution according to Child-Pugh Classification Stage Author’s file.

Published

2026-05-22

How to Cite

Ipia Ordoñez, N. V., Benavides Melo, J. A., Bastidas Riascos, M., Madroñero Muñoz, S. D., Vélez Rosales, A. J., & Taramuel Gómez , D. F. (2026). Etiological Pattern of Liver Cirrhosis: Experience at a Hospital in Southwestern Colombia. Revista Colombiana De Gastroenterología, 41(2), 161–167. https://doi.org/10.22516/25007440.1507

Issue

Section

Originals articles

Altmetric

Escanea para compartir
QR Code
Crossref Cited-by logo
Article metrics
Abstract views763
Galley views331
PDF Views305
HTML views0
Other views26

Some similar items: